Part 2: New and effective antimalarial drugs in global malaria elimination strategies
The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India.
Roy M, Bouma MJ, Ionides EL, Dhiman RC, Pascual M.PLoS Negl Trop Dis. 2013;7(1):e1979. doi: 10.1371/journal.pntd.0001979.Epub 2013 Jan 10.PMID: 23326611Free PMC Article Similar articles Select item 28381261
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.
Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, Sattabongkot J, Jambert E, Domingo GJ, Commons R, Auburn S, Marfurt J, Devine A, Aktaruzzaman MM, Sohel N, Namgay R, Drukpa T, Sharma SN, Sarawati E, Samad I, Theodora M, Nambanya S, Ounekham S, Mudin RN, Da Thakur G, Makita LS, Deray R, Lee SE, Boaz L, Danansuriya MN, Mudiyanselage SD, Chinanonwait N, Kitchakarn S, Nausien J, Naket E, Duc TN, Do Manh H, Hong YS, Cheng Q, Richards JS, Kusriastuti R, Satyagraha A, Noviyanti R, Ding XC, Khan WA, Swe Phru C, Guoding Z, Qi G, Kaneko A, Miotto O, Nguitragool W, Roobsoong W, Battle K, Howes RE, Roca-Feltrer A, Duparc S, Bhowmick IP, Kenangalem E, Bibit JA, Barry A, Sintasath D, Abeyasinghe R, Sibley CH, McCarthy J, von Seidlein L, Baird JK, Price RN.
Malar J. 2017 Apr 5;16(1):141. doi: 10.1186/s12936-017-1784-1. Review.
PMID: 28381261Free PMC Article Similar articles Select item 23797843
An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model.
Jin X, Pybus BS, Marcsisin R, Logan T, Luong TL, Sousa J, Matlock N, Collazo V, Asher C, Carroll D, Olmeda R, Walker LA, Kozar MP, Melendez V.Eur J Drug Metab Pharmacokinet.2014 Jun;39(2):139-46.PMID: 23797843Similar articles Select item 30565279
Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: A systematic review and meta-analysis.
Zhang X, Xiang Q, Zhao X, Ma L, Cui Y.J Clin Pharm Ther. 2018 Dec 18. doi: 10.1111/jcpt.12780. [Epub ahead of print] Review.PMID: 30565279Similar articles Select item 27188854
Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants.
Jin X, Potter B, Luong TL, Nelson J, Vuong C, Potter C, Xie L, Zhang J, Zhang P, Sousa J, Li Q, Pybus BS, Kreishman-Deitrick M, Hickman M, Smith PL, Paris R, Reichard G, Marcsisin SR.Malar J. 2016 May 17;15(1):280. doi: 10.1186/s12936-016-1329-z.PMID: 27188854Free PMC Article Similar articles Select item 27016470
Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
Marcsisin SR, Reichard G, Pybus BS.Pharmacol Ther. 2016 May;161:1-10. doi: 10.1016/j.pharmthera.2016.03.011. Epub 2016 Mar 22. Review.PMID: 27016470Free Article Similar articles Select item 25891812
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
Campo B, Vandal O, Wesche DL, Burrows JN.Pathog Glob Health. 2015 May;109(3):107-22. doi: 10.1179/2047773215Y.0000000013. Epub 2015 Apr 18. Review.PMID: 25891812Free PMC Article Similar articles Select item 30400893
Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines.
Berman J, Brown T, Dow G, Toovey S.Malar J. 2018 Nov 6;17(1):407. doi: 10.1186/s12936-018-2555-3. Review.PMID: 30400893Free PMC Article Similar articles
The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of Imipramine.
Nguyen HQ, Callegari E, Obach RS.Drug Metab Dispos. 2016 Oct;44(10):1569-78. doi: 10.1124/dmd.116.071639. Epub 2016 Jul 20.PMID: 27440861Similar articles Select item 25759576
Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.
Melariri P, Kalombo L, Nkuna P, Dube A, Hayeshi R, Ogutu B, Gibhard L, deKock C, Smith P, Wiesner L, Swai H.Int J Nanomedicine. 2015 Feb 20;10:1493-503. doi: 10.2147/IJN.S76317. eCollection 2015.PMID: 25759576Free PMC Article Similar articles Select item 29676238
Effect of CYP2D6 Poor Metabolizer Phenotype on Stereoselective Nebivolol Pharmacokinetics.
Vieira CP, Neves DV, Coelho EB, Lanchote VL.Drug Metab Lett. 2018;12(1):68-70. doi: 10.2174/1872312812666180420104945.PMID: 29676238Similar articles Select item 30058787
CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting.
Niewi?ski PA, Wojciechowski R, ?liwi?ski M, Hurkacz ME, G?owacka K, Orzechowska-Juzwenko K, Wiela-Hoje?ska AK.Adv Clin Exp Med. 2018 Nov;27(11):1499-1503. doi: 10.17219/acem/69451.PMID: 30058787Free Article Similar articles Select item 3542534
Pharmacokinetics of primaquine in patients with P. vivax malaria.
Bhatia SC, Saraph YS, Revankar SN, Doshi KJ, Bharucha ED, Desai ND, Vaidya AB, Subrahmanyam D, Gupta KC, Satoskar RS.Eur J Clin Pharmacol.1986;31(2):205-10. PMID: 3542534Similar articles Select item 28836792
Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
Kumar H, Gothwal A, Khan I, Nakhate KT, Alexander A, Ajazuddin, Singh V, Gupta U.Mol Pharm. 2017 Oct 2;14(10):3356-3369. doi: 10.1021/acs.molpharmaceut.7b00376. Epub 2017 Sep 11.PMID: 28836792Similar articles Select item 24913163
Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
Nanayakkara NP, Tekwani BL, Herath HM, Sahu R, Gettayacamin M, Tungtaeng A, van Gessel Y, Baresel P, Wickham KS, Bartlett MS, Fronczek FR, Melendez V, Ohrt C, Reichard GA, McChesney JD, Rochford R, Walker LA.Antimicrob Agents Chemother. 2014 Aug;58(8):4737-44. doi: 10.1128/AAC.02674-13. Epub 2014 Jun 9.PMID: 24913163Free PMC Article Similar articles Select item 29510711
The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial.
Cheah PY, Steinkamp N, von Seidlein L, Price RN.BMC Med Ethics. 2018 Mar 6;19(1):19. doi: 10.1186/s12910-018-0259-4.PMID: 29510711Free PMC Article Similar articles Select item 10615272
The evolution of tafenoquine--antimalarial for a new millennium?
Peters W.J R Soc Med. 1999 Jul;92(7):345-52. Review. No abstract available. PMID: 10615272Free PMC Article Similar articles Select item 27721533
Evaluation of pharmacokinetics of single-dose chloroquine in malnourished children with malaria- a comparative study with normally nourished children.
Kadam PP, Gogtay NJ, Karande S, Shah V, Thatte UM.Indian J Pharmacol. 2016 Sep-Oct;48(5):498-502.PMID: 27721533Free PMC Article Similar articles Select item 29869298
Application of the Stable Isotope Label Approach in Clinical Development-Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound.
Goyal N, Mohamed K, Rolfe K, Sahota S, Ernest T, Duparc S, Taylor M, Casillas L, Koh GCKW.AAPS J. 2018 Jun 4;20(4):74. doi: 10.1208/s12248-018-0234-5.PMID: 29869298Similar articles Select item 22399238
The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humans.
Helldén A, Panagiotidis G, Johansson P, Waters N, Waters S, Tedroff J, Bertilsson L.Eur J Clin Pharmacol. 2012 Sep;68(9):1281-6. doi: 10.1007/s00228-012-1248-z. Epub 2012 Mar 8.PMID: 22399238Similar articles Select item 29317838
Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventingPlasmodium vivax recurrent episodes in Suriname.
Mac Donald-Ottevanger MS, Adhin MR, Jitan JK, Bretas G, Vreden SG.Infect Drug Resist. 2017 Dec 20;11:3-8. doi: 10.2147/IDR.S135897. eCollection 2018.PMID: 29317838Free PMC Article Similar articles Select item 27093859
Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes.
Fasinu PS, Avula B, Tekwani BL, Nanayakkara NP, Wang YH, Bandara Herath HM, McChesney JD, Reichard GA, Marcsisin SR, Elsohly MA, Khan SI, Khan IA, Walker LA.Malar J. 2016 Apr 19;15:224. doi: 10.1186/s12936-016-1270-1.PMID: 27093859Free PMC Article Similar articles Select item 13793053
Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report.
ALVING AS, JOHNSON CF, TARLOV AR, BREWER GJ, KELLERMEYER RW, CARSON Free PMC Article Similar articles Select item 22144436
Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations.
Myint HY, Berman J, Walker L, Pybus B, Melendez V, Baird JK, Ohrt C.Am J Trop Med Hyg. 2011 Dec;85(6):1010-4. doi: 10.4269/ajtmh.2011.11-0498. Review.PMID: 22144436Free PMC Article Similar articles Select item 25295216
Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax.
Rajgor DD, Gogtay NJ , Kadam VS, Kocharekar MM, Parulekar MS, Dalvi SS, Vaidya AB Free PMC Article Similar articles Select item 24360370
Single-dose radical cure of Plasmodium vivax: a step closer.
Price RN, Nosten F.Lancet. 2014 Mar 22;383(9922):1020-1. doi: 10.1016/S0140-6736(13)62672-0. Epub 2013 Dec 19. No abstract available. PMID: 24360370Free PMC Article Similar articles Select item 30706164
Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers.
Ariffin NM , Islahudin F, Kumolosasi E, Makmor-Bakry M.Parasitol Res. 2019 Jan 31. doi: 10.1007/s00436-019-06210-3. [Epub ahead of print]PMID: 30706164Similar articles Select item 29713556
Relapsing Malaria: A Case Report of Primaquine Resistance.
Dijanic C, Nickerson J, Shakya S, Dijanic A, Fabbri M.Case Rep Infect Dis. 2018 Mar 11;2018:9720823. doi: 10.1155/2018/9720823. eCollection 2018.PMID: 29713556Free PMC Article Similar articles
Chloroquine-Primaquine Therapeutic Efficacy, Safety, and Plasma Levels in Patients with UncomplicatedPlasmodium vivax Malaria in a Colombian Pacific Region.
Mesa-Echeverry E, Niebles-Bolívar M, Tobón-Castaño A.Am J Trop Med Hyg. 2019 Jan;100(1):72-77. doi: 10.4269/ajtmh.18-0655.PMID: 30457097Similar articles Select item 14804087
Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report.
Edgcomb jh, arnold Similar articles Select item 25385861
Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects.
Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK, Noedl H, Kochar SK, Kochar DK, Krudsood S, Lacerda MV, Llanos-Cuentas A, Rueangweerayut R, Srinivasan R, Treiber M, Möhrle JJ, Green J.
Am J Trop Med Hyg. 2015 Jan;92(1):22-7. doi: 10.4269/ajtmh.14-0298. Epub 2014 Nov 10.
PMID: 25385861Free PMC Article Similar articles Select item 28070879
A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.
Elewa H, Wilby KJ.Eur J Drug Metab Pharmacokinet. 2017 Oct;42(5):745-756. doi: 10.1007/s13318-016-0399-1. Review.PMID: 28070879Similar articles Select item 30229442
Tafenoquine: First Global Approval.
Frampton JE.Drugs. 2018 Sep;78(14):1517-1523. doi: 10.1007/s40265-018-0979-2.PMID: 30229442Similar articles Select item 30380095
Tafenoquine for travelers' malaria: evidence, rationale and recommendations.
Baird JK.J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay110.PMID: 30380095Free PMC Article Similar articles Select item 28350251
Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study.
Chaudhry M, Alessandrini M, Rademan J, Dodgen TM, Steffens FE, van Zyl DG, Gaedigk A, Pepper MS.Pharmacogenomics. 2017 Apr;18(5):433-443. doi: 10.2217/pgs-2016-0185. Epub 2017 Mar 28.PMID: 28350251Free Article Similar articles Select item 27072954
Minimization of CYP2D6 Polymorphic Differences and Improved Bioavailability via Transdermal Administration: Latrepirdine Example.
Chew ML, Mordenti J, Yeoh T, Ranade G, Qiu R, Fang J, Liang Y, Corrigan B.Pharm Res. 2016 Aug;33(8):1873-80. doi: 10.1007/s11095-016-1922-4. Epub 2016 Apr 12.PMID: 27072954Similar articles Select item 30670877
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.
Smith DM, Weitzel KW, Elsey AR, Langaee T, Gong Y, Wake DT, Duong BQ, Hagen M, Harle CA, Mercado E, Nagoshi Y, Newsom K, Wright A, Rosenberg EI, Starostik P, Clare-Salzler MJ, Schmidt SO, Fillingim RB, Johnson JA, Cavallari LH.Genet Med. 2019 Jan 23. doi: 10.1038/s41436-018-0431-8. [Epub ahead of print]. PMID: 30670877Similar articles Select item 14945979
Cure of Korean vivax malaria with pamaquine and primaquine.
GARRISON PL, HANKEY DD, COKER WG, DONOVAN WN, JASTREMSKI B, COATNEY GR, ALVING AS, JONES R Jr.J Am Med Assoc. 1952 Aug 23;149(17):1562-3. No abstract available. PMID: 14945979Similar articles Select item 26528073
Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers.
Briciu C, Neag M, Muntean D, Bocsan C, Buzoianu A, Antonescu O, Gheldiu AM, Achim M, Popa A, Vlase L.Clujul Med. 2015;88(2):208-13. doi: 10.15386/cjmed-395. Epub 2015 Apr 15.PMID: 26528073Free PMC Article Similar articles Select item 21970596
Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment.
Lorizio W, Rugo H, Beattie MS, Tchu S, Melese T, Melisko M, Wu AH, Lawrence Free PMC Article Similar articles Select item 14419205
Use of quinocide in treatment and prophylaxis of vivax malaria.
LYSENKO AY.Bull World Health Organ. 1960;22:641-62.PMID: 14419205Free PMC Article Similar articles Select item 27223244
Methemoglobinemia Hemotoxicity of Some Antimalarial 8-Aminoquinoline Analogues and Their Hydroxylated Derivatives: Density Functional Theory Computation of Ionization Potentials.
Ding Y, Liu H, Tekwani BL, Nanayakkara NP, Khan IA, Walker LA, Doerksen RJ.
Chem Res Toxicol. 2016 Jul 18;29(7):1132-41. doi: 10.1021/acs.chemrestox.6b00063. Epub 2016 Jul 1.
PMID: 27223244Similar articles Select item 30650321
Tafenoquine - A Radical Improvement?
White NJ .
N Engl J Med. 2019 Jan 17;380(3):285-286. doi: 10.1056/NEJMe1816383. No abstract available.
PMID: 30650321Similar articles Select item 30485867
The Associations Between CYP2D6 Metabolizer Status and Pharmacokinetics and Clinical Outcomes of Venlafaxine: A Systematic Review and Meta-Analysis.
Lin XQ, Wang P, Cai WK, Xu GL, Yang M, Zhou MD, Sun M, He F, He GH.
Pharmacopsychiatry. 2018 Nov 28. doi: 10.1055/a-0792-1340. [Epub ahead of print]
PMID: 30485867Similar articles Select item 20343588
Pentaquine (SN-13,276) a new antimalarial effective in reducing the relapse rate of vivax malaria.
PULLMAN TN, ALVING AS, et al.
Proc Annu Meet Cent Soc Clin Res U S. 1946 Nov 1-2;19:83. No abstract available.
PMID: 20343588Similar articles Select item 21064280
Pamaquin; curative antimalarial activity in vivax malaria.
BERLINER RW, TAGGART JV, et al.
Fed Proc. 1946;5(1 Pt 2):165. No abstract available.
PMID: 21064280Similar articles Select item 23965782
Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor.
Raddad E, Melhem MR, Sloan-Lancaster JS, Miller JW, Van Wart SA, Rubino CM.
CPT Pharmacometrics Syst Pharmacol. 2013 Aug 21;2:e66. doi: 10.1038/psp.2013.43.
PMID: 23965782Free PMC Article Similar articles Select item 18872928
Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria.
ALVING AS.
Abstr Int Congr Trop Med Malar. 1948;56(4th Congr):58. No abstract available.
PMID: 18872928Similar articles
Combined quinine-plasmochin treatment of vivax malaria; effect of relapse rate.
MOST H, KANE CA, et al.
Am J Med Sci. 1946 Nov;212(5):550-60. No abstract available.
PMID: 20273918Similar articles Select item 29301387
Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease.
Cacabelos R, Meyyazhagan A, Carril JC, Cacabelos P, Teijido Ó.
J Pers Med. 2018 Jan 3;8(1). pii: E3. doi: 10.3390/jpm8010003. Review.
PMID: 29301387Free PMC Article Similar articles Select item 18905562
Combined quinine-plasmochin and quinine-pentaquine treatment of relapsing vivax malaria.
SPICKNALL CG, TERRY LL.
South Med J. 1948 Apr;41(4):338-41. No abstract available.
PMID: 18905562Similar articles Select item 14790523
Radical cure of relapsing vivax malaria with pentaquine-quinine; a controlled study.
STRAUS B, GENNIS J.
Ann Intern Med. 1950 Dec;33(6):1413-22.No abstract available.
PMID: 14790523Similar articles Select item 18121216
Studies in human malaria; the therapeutic action of pamaquine against St. Elizabeth strain vivax malaria.
RUHE DS, COOPER WC, et al.
Am J Hyg. 1949 May;49(3):367-73. No abstract available.
PMID: 18121216Similar articles Select item 18860176
Pentaquine (SN-13,276) a therapeutic agent effective in reducing the relapse rate in vivax malaria.
ALVING AS, CRAIGE B Jr, et al.
J Clin Invest. 1948 May;27(3 Pt1):25-33. No abstract available.
PMID: 18860176Similar articles Select item 18860470
Evaluation of pentaquine as a cure of relapsing vivax malaria; a controlled study of 95 cases.
STRAUS B, GENNIS J.
Bull N Y Acad Med. 1948 Jun;24(6):395. No abstract available.
PMID: 18860470Free PMC Article Similar articles Select item 14795202
Studies in human malaria. XXVII. Observations on the use of pentaquine in the prevention and treatment of Chesson strain vivax malaria.
COATNEY GR, COOPER WC, EYLES DE, CULWELL WB, WHITE WC, LINTS HA.
J Natl Malar Soc. 1950 Sep;9(3):222-33. No abstract available.
PMID: 14795202Similar articles Select item 18123173
Cure of chronic vivax malaria with pentaquine.
COGGESHALL LT, RICE FA.
J Am Med Assoc. 1949 Feb 12;139(7):437-9. No abstract available.
PMID: 18123173Similar articles Select item 18152607
Cure of chronic vivax malaria with pentaquine and status of immunity thereafter.
COGGESHALL LT.
Proc Inst Med Chic. 1949 Jun 15;17(15):357. No abstract available.
PMID: 18152607Similar articles Select item 30137454
Tafenoquine receives regulatory approval in USA for prophylaxis of malaria and radical cure of Plasmodium vivax.
Tan KR, Hwang J.
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay071. No abstract available.
PMID: 30137454Similar articles Select item 24266826
On naturalistic pharmacogenetic studies: reply from the authors.
Seip RL, Goethe JW, Schwartz HI, Ruaño G.
Biomark Med. 2013 Dec;7(6):917-8. doi: 10.2217/bmm.13.110. No abstract available.
PMID: 24266826Free Article Similar articles Select item 29389962
Correction: Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.
Silvino ACR, Costa GL, Araújo FCF, Ascher DB, Pires DEV, Fontes CJF, Carvalho LH, Brito CFA, Sousa TN.
PLoS one. 2018 Feb 1;13(2):e0192534. doi: 10.1371/journal.pone.0192534. eCollection 2018.
PMID: 29389962Free PMC Article Similar articles Select item 28729716
Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.
Dodgen TM, De J Labuschagne C, van Schalkwyk A, Steffens FE, Gaedigk A, Cromarty AD, Alessandrini M, Pepper MS.
Pharmacogenomics J. 2017 Jul;17(4):393. doi: 10.1038/tpj.2017.20.
PMID: 28729716Similar articles
Tafenoquine for travelers' malaria: evidence, rationale and recommendations.
Baird JK.
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay110.
PMID: 30380095Free PMC Article Similar articles Select item 30229442
Tafenoquine: First Global Approval.
Frampton JE.
Drugs. 2018 Sep;78(14):1517-1523. doi: 10.1007/s40265-018-0979-2.
PMID: 30229442Similar articles Select item 28883977
Management ofPlasmodium vivax risk and illness in travelers.
Baird JK.
Trop Dis Travel Med Vaccines. 2017 Mar 28;3:7. doi: 10.1186/s40794-017-0049-x. eCollection 2017.
PMID: 28883977Free PMC Article Similar articles Select item 29677199
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J, Taylor WRJ, Bancone G, Chu CS, Jittamala P, White NJ
PLoS Negl Trop Dis. 2018 Apr 20;12(4):e0006440. doi: 10.1371/journal.pntd.0006440. eCollection 2018 Apr.
PMID: 29677199Free PMC Article Similar articles Select item 24360369
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Möhrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L.
Lancet. 2014 Mar 22;383(9922):1049-58. doi: 10.1016/S0140-6736(13)62568-4. Epub 2013 Dec 19.
PMID: 24360369Similar articles Select item 27528800
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.
Ebstie YA, Abay SM, Tadesse WT, Ejigu DA.
Drug Des Devel Ther. 2016 Jul 26;10:2387-99. doi: 10.2147/DDDT.S61443. eCollection 2016. Review.
PMID: 27528800Free PMC Article Similar articles Select item 15486831
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS, Wilairatana P, Tang DB, Heppner DG Jr, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S.
Clin Infect Dis. 2004 Oct 15;39(8):1095-103. Epub 2004 Sep 24.
PMID: 15486831Similar articles Select item 30400893
Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines.
Berman J, Brown T, Dow G, Toovey S.
Malar J. 2018 Nov 6;17(1):407. doi: 10.1186/s12936-018-2555-3. Review.
PMID: 30400893Free PMC Article Similar articles Select item 29121061
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
Fukuda MM, Krudsood S, Mohamed K, Green JA, Warrasak S, Noedl H, Euswas A, Ittiverakul M, Buathong N, Sriwichai S, Miller RS, Ohrt C.
PLoS one. 2017 Nov 9;12(11):e0187376. doi: 10.1371/journal.pone.0187376. eCollection 2017.
PMID: 29121061Free PMC Article Similar articles Select item 18541280
The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
Elmes NJ , Nasveld PE
Trans R Soc Trop Med Hyg. 2008 Nov;102(11):1095-101. doi: 10.1016/j.trstmh.2008.04.024.Epub 2008 Jun 9.
PMID: 18541280Similar articles Select item 28417346
[Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S, Pradines B, Basco LK.
Bull Soc Pathol Exot. 2017 Aug;110(3):198-206. doi: 10.1007/s13149-017-0556-z. Epub 2017 Apr 17. Review. French.
PMID: 28417346Similar articles Select item 26880088
UK malaria treatment guidelines 2016.
Lalloo DG, Shingadia D, Bell DJ, Beeching NJ , Whitty CJM, Chiodini PL UK
J Infect. 2016 Jun;72(6):635-649. doi: 10.1016/j.jinf.2016.02.001.Epub 2016 Feb 12.
PMID: 26880088 Similar articles Select item 21801400 13.
Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
Dow GS, Gettayacamin M, Hansukjariya P, Imerbsin R, Komcharoen S, Sattabongkot J, Kyle D, Milhous W, Cozens S, Kenworthy D, Miller A, Veazey J, Ohrt C.
Malar J. 2011 Jul 29;10:212. doi: 10.1186/1475-2875-10-212.
PMID: 21801400Free PMC Article Similar articles Select item 24502679
A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.
Dow GS, McCarthy WF, Reid M, Smith B, Tang D, Shanks GD.
Malar J. 2014 Feb 6;13:49. doi: 10.1186/1475-2875-13-49.
PMID: 24502679Free PMC Article Similar articles Select item 23454204
Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.
Baird JK.
Travel Med Infect Dis. 2013 Jan-Feb;11(1):60-5. doi: 10.1016/j.tmaid.2013.01.002. Epub 2013 Feb 28.
PMID: 23454204Free PMC Article Similar articles Select item 26654101
Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
Nelwan EJ, Ekawati LL, Tjahjono B, Setiabudy R, Sutanto I, Chand K, Ekasari T, Djoko D, Basri H, Taylor WR, Duparc S, Subekti D, Elyazar I, Noviyanti R, Sudoyo H, Baird JK.
BMC Med. 2015 Dec 11;13:294. doi: 10.1186/s12916-015-0535-9.
PMID: 26654101Free PMC Article Similar articles Select item 25482427
Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.
Shimizu S, Kikuchi T, Koga M, Kato Y, Matsuoka H, Maruyama H, Kimura M; Research Group on Chemotherapy of Tropical Diseases.
Travel Med Infect Dis. 2015 May-Jun;13(3):235-40. doi: 10.1016/j.tmaid.2014.11.005. Epub 2014 Nov 20.
PMID: 25482427Similar articles Select item 23484374
[Clinical experience of primaquine use for treatment of vivax and ovale malaria in Japanese travelers].
Kobayashi T, Kato Y, Yamauchi Y, Ujiie M, Takeshita N, Mizuno Y, Kanagawa S, Kano S, Ohmagari N.
Kansenshogaku Zasshi. 2013 Jan;87(1):22-6. Japanese.
PMID: 23484374Similar articles Select item 21508921
Malaria surveillance--United States, 2009.
Mali S, Tan KR, Arguin PM; Division of Parasitic Diseases and Malaria, Center for Global Health; Centers for Disease Control and Prevention.
MMWR Surveill Summ. 2011 Apr 22;60(3):1-15.
PMID: 21508921Free Article Similar articles
Select item 28749773
Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.
Rueangweerayut R, Bancone G, Harrell EJ, Beelen AP, Kongpatanakul S, Möhrle JJ, Rousell V, Mohamed K, Qureshi A, Narayan S, Yubon N, Miller A, Nosten FH, Luzzatto L, Duparc S, Kleim JP, Green JA.
Am J Trop Med Hyg. 2017 Sep;97(3):702-711. doi: 10.4269/ajtmh.16-0779. Epub 2017 Jul 27.
PMID: 28749773Free PMC Article Similar articles
Malaria Surveillance - United States, 2015.
Mace KE, Arguin PM, Tan KR.
MMWR Surveill Summ. 2018 May 4;67(7):1-28. doi: 10.15585/mmwr.ss6707a1.
PMID: 29723168Free PMC Article Similar articles Select item 17461742
Tafenoquine: a promising new antimalarial agent.
Crockett M, Kain KC.
Expert Opin Investig Drugs. 2007 May;16(5):705-15. Review.
PMID: 17461742Similar articles Select item 12711101
Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys.
Puri SK , Dutta GP.
Acta Trop. 2003 Apr;86(1):35-40.
PMID: 12711101Similar articles Select item 26652887
Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
Baird JK.
BMC Med. 2015 Dec 14;13:296. doi: 10.1186/s12916-015-0531-0.
PMID: 26652887Free PMC Article Similar articles Select item 29672516
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
Recht J, Ashley EA, White NJ.
PLoS Negl Trop Dis. 2018 Apr 19;12(4):e0006230. doi: 10.1371/journal.pntd.0006230. eCollection 2018 Apr. Review.
PMID: 29672516Free PMC Article Similar articles Select item 15541223
Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers.
Elliott JH, O'Brien D, Leder K, Kitchener S, Schwartz E, Weld L, Brown GV, Kain KC, Torresi J; GeoSentinel Surveillance Network.
J Travel Med. 2004 Jul-Aug;11(4):213-7.
PMID: 15541223Free Article Similar articles Select item 27077309
Primaquine treatment and relapse in Plasmodium vivax malaria.
Rishikesh K, Saravu K.
Pathog Glob Health. 2016;110(1):1-8. doi: 10.1080/20477724.2015.1133033. Epub 2016 Feb 18. Review.
PMID: 27077309Free PMC Article Similar articles Select item 27530139
Management of relapsing Plasmodium vivax malaria.
Chu CS, White NJ
Expert Rev Anti Infect Ther. 2016 Oct;14(10):885-900. doi: 10.1080/14787210.2016.1220304. Epub 2016 Aug 31. Review.
PMID: 27530139Free PMC Article Similar articles Select item 11438908
Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.
Shanks GD, Kain KC, Keystone JS.
Clin Infect Dis. 2001 Aug 1;33(3):381-5. Epub 2001 Jul 5. Review.
PMID: 11438908Similar articles Select item 15701554
New strategies for the prevention of malaria in travelers.
Chen LH, Keystone JS.
Infect Dis Clin North Am. 2005 Mar;19(1):185-210. Review.
PMID: 15701554Similar articles Select item 11584657
Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
Edstein MD, Walsh DS, Eamsila C, Sasiprapha T, Nasveld PE
Med Trop (Mars). 2001;61(1):56-8. Review.
PMID: 11584657Similar articles Select item 22377962
Malaria surveillance--United States, 2010.
Mali S, Kachur SP, Arguin PM; Division of Parasitic Diseases and Malaria, Center for Global Health; Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2012 Mar 2;61(2):1-17.
PMID: 22377962Free Article Similar articles Select item 27109040
Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax.
Thomas D, Tazerouni H, Sundararaj KG, Cooper JC.
Acta Trop. 2016 Aug;160:35-8. doi: 10.1016/j.actatropica.2016.04.009. Epub 2016 Apr 21. Review.
PMID: 27109040Similar articles Select item 28542123
Malaria Surveillance - United States, 2014.
Mace KE, Arguin PM.
MMWR Surveill Summ. 2017 May 26;66(12):1-24. doi: 10.15585/mmwr.ss6612a1.
PMID: 28542123Free PMC Article Similar articles Select item 19995933
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.
Nasveld PE, Edstein MD, Reid M, Brennan L, Harris IE, Kitchener SJ, Leggat PA, Pickford P, Kerr C, Ohrt C, Prescott W; Tafenoquine Study Team.
Antimicrob Agents Chemother. 2010 Feb;54(2):792-8. doi: 10.1128/AAC.00354-09. Epub 2009 Dec 7.
PMID: 19995933Free PMC Article Similar articles Select item 17360873
Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
Kitchener S, Nasveld P, Edstein MD.
Am J Trop Med Hyg. 2007 Mar;76(3):494-6.
PMID: 17360873Similar articles Select item 23199489
Diagnosis and treatment of Plasmodium vivax malaria.
Baird KJ, Maguire JD, Price RN.
Adv Parasitol. 2012;80:203-70. doi: 10.1016/B978-0-12-397900-1.00004-9. Review.
PMID: 23199489Similar articles Select item 28857064
Implementation of G6PD testing and primaquine forP. vivax radical cure: Operational perspectives from Thailand and Cambodia.
Kitchakarn S, Lek D, Thol S, Hok C, Saejeng A, Huy R, Chinanonwait N, Thimasarn K, Wongsrichanalai C.
WHO South East Asia J Public Health. 2017 Sep;6(2):60-68.
PMID: 28857064Free Article Similar articles Select item 25495607
The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea.
Ingram RJ, Crenna-Darusallam C, Soebianto S, Noviyanti R, Baird JK.
Malar J. 2014 Dec 12;13:488. doi: 10.1186/1475-2875-13-488.
PMID: 25495607Free PMC Article Similar articles Select item 25474160
Malaria surveillance--United States, 2012.
Cullen KA, Arguin PM; Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2014 Dec 5;63(12):1-22.
PMID: 25474160Free Article Similar articles
Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Kheng S, Muth S, Taylor WR, Tops N, Kosal K, Sothea K, Souy P, Kim S, Char CM, Vanna C, Ly P, Ringwald P, Khieu V, Kerleguer A, Tor P, Baird JK, Bjorge S, Menard D, Christophel E.
BMC Med. 2015 Aug 25;13:203. doi: 10.1186/s12916-015-0441-1.
PMID: 26303162Free PMC Article Similar articles Select item 17090770
Prevention of malaria in long-term travelers.
Chen LH, Wilson ME, Schlagenhauf P.
JAMA. 2006 Nov 8;296(18):2234-44. Review.
PMID: 17090770Similar articles Select item 16968913
Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.
Hill DR , Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ.
Am J Trop Med Hyg. 2006 Sep;75(3):402-15.
PMID: 16968913Similar articles Select item 26938139
Malaria Surveillance - United States, 2013.
Cullen KA, Mace KE, Arguin PM; Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2016 Mar 4;65(2):1-22. doi: 10.15585/mmwr.ss6502a1.
PMID: 26938139Similar articles Select item 15378438
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
Walsh DS, Eamsila C, Sasiprapha T, Sangkharomya S, Khaewsathien P, Supakalin P, Tang DB, Jarasrumgsichol P, Cherdchu C, Edstein MD, Rieckmann KH, Brewer TG.
J Infect Dis. 2004 Oct 15;190(8):1456-63. Epub 2004 Sep 20.
PMID: 15378438Similar articles Select item 17557074
Malaria surveillance - United States, 2005.
Thwing J, Skarbinski J, Newman RD, Barber AM, Mali S, Roberts JM, Slutsker L, Arguin PM; Centers for Disease Control and Prevention.
MMWR Surveill Summ. 2007 Jun 8;56(6):23-40.
PMID:17557074Free Article S imilar articles Select item 10323359
Malaria prevention in travelers.
Juckett G.
Am Fam Physician. 1999 May 1;59(9):2523-30, 2535-6. Review. Erratum in: Am Fam Physician 2000 Jan 1;61(1):50, 52.
PMID: 10323359Free Article Similar articles Select item 10885356
Malaria chemoprophylaxis with tafenoquine: a randomised study.
Lell B, Faucher JF, Missinou MA, Borrmann S, Dangelmaier O, Horton J, Kremsner PG.
Lancet. 2000 Jun 10;355(9220):2041-5.
PMID: 10885356Similar articles Select item 23254437
Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA, Setiabudy R, Nurleila S, Ekawati LL, Elyazar I, Farrar J, Sudoyo H, Baird JK.
Antimicrob Agents Chemother. 2013 Mar;57(3):1128-35. doi: 10.1128/AAC.01879-12. Epub 2012 Dec 17.
PMID: 23254437Free PMC Article Similar articles Select item 23863769
Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011.
Harvey K, Esposito DH, Han P, Kozarsky P, Freedman DO, Plier DA, Sotir MJ; Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2013 Jul 19;62:1-23.
PMID: 23863769Free Article Similar articles Select item 26643116
Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
IMPROV Study Group.
BMC Infect Dis. 2015 Dec 7;15:558. doi: 10.1186/s12879-015-1276-2.
PMID: 26643116Free PMC Article Similar articles Select item 12875252
Malaria surveillance--United States, 2001.
Filler S, Causer LM, Newman RD, Barber AM, Roberts JM, MacArthur J, Parise ME, Steketee RW; Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2003 Jul 18;52(5):1-14.
PMID: 12875252Free Article Similar articles Select item 26888075
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
St Jean PL, Xue Z, Carter N, Koh GC, Duparc S, Taylor M, Beaumont C, Llanos-Cuentas A, Rueangweerayut R, Krudsood S, Green JA, Rubio JP.
Malar J. 2016 Feb 18;15:97. doi: 10.1186/s12936-016-1145-5.
PMID: 26888075Free PMC Article Similar articles Select item 16723971
Malaria surveillance--United States, 2004.
Skarbinski J, James EM, Causer LM, Barber AM, Mali Newman RD.
MMWR Surveill Summ. 2006 May 26;55(4):23-37.
PMID: 16723971Free Article Similar articles Select item 20577158
Malaria surveillance - United States, 2008.
Mali S, Steele S, Slutsker L, Arguin PM; Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2010 Jun 25;59(7):1-15. Erratum in: MMWR Surveill Summ. 2010 Jul 30;59(29):914.
PMID: 20577158Free Article Similar articles Select item 12625150
Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel.
Nasveld P, Kitchener S, Edstein M, Rieckmann K.
Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):683-4.
PMID: 12625150Similar articles Select item 15931154
Malaria surveillance--United States, 2003.
Eliades MJ, Shah S, Nguyen-Dinh P, Newman RD, Barber AM, Nguyen-Dinh P, Roberts JM, Mali S, Parise ME, Barber AM, Steketee R.
MMWR Surveill Summ. 2005 Jun 3;54(2):25-40.
PMID: 15931154Free Article Similar articles Select item 30269312
Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.
Warrasak S, Euswas A, Fukuda MM, Ittiverakul M, Miller RS, Krudsood S, Ohrt C.
Int Ophthalmol. 2018 Sep 29. doi: 10.1007/s10792-018-1003-2. [Epub ahead of print]
PMID: 30269312Similar articles Select item 26610844
Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.
Dow GS, Liu J, Lin G, Hetzell B, Thieling S, McCarthy WF, Tang D, Smith B.
Malar J. 2015 Nov 26;14:473. doi: 10.1186/s12936-015-0991-x.
PMID: 26610844Free PMC Article Similar articles Select item 16225366
Modern malaria chemoprophylaxis.
Shanks GD, Edstein MD.
Drugs. 2005;65(15):2091-110. Review.
PMID: 16225366
Malaria surveillance--United States, 2011.
Cullen KA, Arguin PM; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2013 Nov 1;62(5):1-17.
PMID: 24172939Free Article Similar articles Select item 22144437
Review: Malaria chemoprophylaxis for travelers to Latin America.
Steinhardt LC, Magill AJ, Arguin PM.
Am J Trop Med Hyg. 2011 Dec;85(6):1015-24. doi: 10.4269/ajtmh.2011.11-0464. Review.
PMID: 22144437Free PMC Article Similar articles Select item 1518752
Prophylaxis for malaria. Helping world travelers come home healthy.
Amin NM .
Postgrad Med. 1992 Sep 1;92(3):161-8. Review.
PMID: 1518752Similar articles Select item 11177733
Recent Advances in the Prophylaxis and Treatment of Malaria.
Labbé AC, Loutfy MR, Kain KC.
Curr Infect Dis Rep. 2001 Feb;3(1):68-76.
PMID: 11177733Similar articles Select item 10585803
Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
Schwartz E, Regev-Yochay G.
Clin Infect Dis. 1999 Dec;29(6):1502-6.
PMID: 10585803Similar articles Select item 18682739
A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan.
Leslie T, Mayan I, Mohammed N, Erasmus P, Kolaczinski J, Whitty CJ, Rowland M.
PLoS one. 2008 Aug 6;3(8):e2861. doi: 10.1371/journal.pone.0002861.
PMID:18682739Free PMC Article Similar articles Select item 15123983
Malaria surveillance--United States, 2002.
Shah S, Filler S, Causer LM, Rowe AK
MMWR Surveill Summ. 2004 Apr 30;53(1):21-34.
PMID: 15123983Free Article Similar articles Select item 14689349
Primaquine for prevention of malaria in travelers.
Baird JK, Fryauff DJ, Hoffman SL.
Clin Infect Dis. 2003 Dec 15;37(12):1659-67. Epub 2003 Nov 20.
PMID: 14689349Similar articles Select item 18566568
Malaria surveillance--United States, 2006.
Mali S, Steele S, Slutsker L, Arguin PM; Centers for Disease Control and Prevention (CDC).
MMWR Surveill Summ. 2008 Jun 20;57(5):24-39.
PMID: 18566568Free Article Similar articles Select item 26500351
Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
Beck HP, Wampfler R, Carter N, Koh G, Osorio L, Rueangweerayut R, Krudsood S, Lacerda MV, Llanos-Cuentas A, Duparc S, Rubio JP, Green JA.
J Infect Dis. 2016 Mar 1;213(5):794-9. doi: 10.1093/infdis/jiv508.Epub 2015 Oct 23.
PMID: 26500351Free PMC Article Similar articles Select item 15550254
Treatment of acute vivax malaria with tafenoquine.
Nasveld P, Kitchener S.
Trans R Soc Trop Med Hyg. 2005 Jan;99(1):2-5.
PMID: 15550254Similar articles Select item 11736877
Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers.
Edstein MD, Kocisko DA, Brewer TG, Walsh DS, Eamsila C, Charles BG.
Br J Clin Pharmacol. 2001 Dec;52(6):663-70.
PMID: 11736877Free PMC Article Similar articles Select item 14561793
Delayed onset of malaria--implications for chemoprophylaxis in travelers.
Schwartz E, Parise M, Kozarsky P, Cetron M.
N Engl J Med. 2003 Oct 16;349(16):1510-6.
PMID: 14561793Free Article Similar articles Select item 17517850
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects.
Charles BG, Miller AK, Nasveld PE, Reid MG, Harris IE, Edstein MD.
Antimicrob Agents Chemother. 2007 Aug;51(8):2709-15. Epub 2007 May 21.
PMID: 17517850Free PMC Article Similar articles Select item 30201820
Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial.
Thakkar N, Green JA, Koh GCKW, Duparc S, Tenero D, Goyal N.
Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00711-18. doi: 10.1128/AAC.00711-18. Print 2018 Nov.
PMID: 30201820Free PMC Article Similar articles Select item 11700577
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
Shanks GD, Oloo AJ, Aleman GM, Ohrt C, Klotz FW, Braitman D, Horton J, Brueckner R.
Clin Infect Dis. 2001 Dec 15;33(12):1968-74. Epub 2001 Nov 7.
PMID: 11700577Similar articles Select item 26505753
Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
Robinson LJ, Wampfler R, Betuela I, Karl S, White MT, Li Wai Suen CS, Hofmann NE, Kinboro B, Waltmann A, Brewster J, Lorry L, Tarongka N, Samol L, Silkey M, Bassat Q, Siba PM, Schofield L, Felger I, Mueller I.
PLoS Med. 2015 Oct 27;12(10):e1001891. doi: 10.1371/journal.pmed.1001891. eCollection 2015 Oct.
PMID: 26505753Free PMC Article Similar articles Select item 17519415
Controversies and misconceptions in malaria chemoprophylaxis for travelers.
Chen LH, Wilson ME, Schlagenhauf P.
JAMA. 2007 May 23;297(20):2251-63. Review.
PMID: 17519415Similar articles Select item 23984595
[Plasmodium malariae malaria with more than a 4-month incubation period: difficult to distinguish from a relapse of Plasmodium vivax malaria].
Hase R, Uwamino Y, Muranaka K, Tochitani K, Sogi M, Kitazono H, Hosokawa N.
Kansenshogaku Zasshi. 2013 Jul;87(4):446-50. Japanese.
PMID: 23984595Similar articles Select item 11770906
Malaria surveillance--United States, 1998.
Holtz TH, Kachur SP, MacArthur JR, Roberts JM, Barber AM, Steketee RW, Parise ME.
MMWR CDC Surveill Summ. 2001 Dec 7;50(5):1-20.
PMID: 11770906Free Article Similar articles Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
Baird K.Pathog Glob Health. 2015 May;109(3):93-106. doi: 10.1179/2047773215Y.0000000016. Review.PMID: 25943156Free PMC Article Similar articles Select item 25016120
[Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis].
Hatipo?lu M, Ulçay A, Turhan V, Karagöz E, Erdem H, Acar A, oncül O, Görenek L.Turkiye Parazitol Derg. 2014 Jun;38(2):120-3. doi: 10.5152/tpd.2014.3159. Turkish. PMID: 25016120Free Article Similar articles Select item 9815351
Arguments against Chemoprophylaxis in Areas at Low Risk for Chloroquine-Resistant Plasmodium falciparum.
Armengaud M.J Travel Med. 1995 Mar 1;2(1):4-5.PMID: 9815351Free Article Similar articles Select item 23199490
Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria.
Douglas NM, John GK, von Seidlein L, Anstey NM Similar articles Select item 17107431
Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.
Jiménez BC, Navarro M, Huerga H, López-Román E, Mendoza A, López-Vélez R.J Travel Med. 2006 Nov-Dec;13(6):373-5.PMID: 17107431Free Article Similar articles Select item 14296004
Latent infections with Plasmodium ovale malaria.
MILLER MJ, MARCUS DM, CAMERON DG.Can Med Assoc J. 1965 Jun 12;92:1241-7.PMID: 14296004Free PMC Article Similar articles Select item 12594633
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
Hale BR, Owusu-Agyei S, Fryauff DJ, Koram KA, Adjuik M, Oduro AR, Prescott WR, Baird JK, Nkrumah F, Ritchie TL, Franke ED, Binka FN, Horton J, Hoffman SL.Clin Infect Dis. 2003 Mar 1;36(5):541-9. Epub 2003 Feb 14.PMID: 12594633Similar articles Select item 16837719
Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center.
Bottieau E, Clerinx J, Van Den Enden E, Van Esbroeck M, Colebunders R, Van Gompel A, Van Den Ende J.Am J Trop Med Hyg. 2006 Jul;75(1):133-8.PMID: 16837719Similar articles Select item 16814823
Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis.
Edstein MD, Nasveld PE, Kocisko DA, Kitchener SJ, Gatton ML, Rieckmann KH.Trans R Soc Trop Med Hyg. 2007 Mar;101(3):226-30. Epub 2006 Jun 30.PMID: 16814823Similar articles Select item 28450185
Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A meta-analysis and systematic review.
Kolifarhood G, Raeisi A, Ranjbar M, Haghdoust AA, Schapira A, Hashemi S, Masoumi-Asl H, Mozafar Saadati H, Azimi S, Khosravi N, Kondrashin A.Travel Med Infect Dis. 2017 May - Jun;17:5-18. doi: 10.1016/j.tmaid.2017.04.005. Epub 2017 Apr 24. Review.PMID: 28450185Similar articles Select item 12420905
Malaria surveillance--United States, 1999.
Newman RD , Barber AM, Roberts J, Holtz T, Steketee RW, Parise ME.MMWR Surveill Summ. 2002 Mar 29;51(1):15-28.PMID: 12420905Free Article Similar articles Select item 16256047
Risk and spectrum of diseases in travelers to popular tourist destinations.
Rack J, Wichmann O, Kamara B, Günther M, Cramer J, Schönfeld C, Henning T, Schwarz U, Mühlen M, Weitzel T, Friedrich-Jänicke B, Foroutan B, Jelinek T.J Travel Med. 2005 Sep-Oct;12(5):248-53.PMID: 16256047Free Article Similar articles Select item 26248362
Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria.
Tenero D, Green JA, Goyal N.Antimicrob Agents Chemother. 2015 Oct;59(10):6188-94. doi: 10.1128/AAC.00718-15. Epub 2015 Jul 27.PMID: 26248362Free PMC Article Similar articles Select item 26930890
Primaquine treatment for Plasmodium vivax-an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I, Robinson LJ, Hetzel MW, Laman M, Siba PM, Bassat Q, Mueller I.P N G Med J. 2014 Mar-Dec;57(1-4):68-74.PMID: 26930890Similar articles Select item 18486067
Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon.
Gallien S, Taieb F, Schlemmer F, Lagrange-Xelot M, Atlan A, Sarfati C, Molina JM.Travel Med Infect Dis. 2008 May;6(3):128-9. doi: 10.1016/j.tmaid.2008.01.011. Epub 2008 Apr 2.PMID: 18486067
HOMEPAGE
Forum
Sitemap
Contact
Vietnamese
Petechial fever
